ALI HEALTH (00241.HK) Grants 3.88 Million RSUs to 20 Employees; 1.55 Billion Shares Remain Available Under 2024 Scheme

Bulletin Express03-13 20:41

Alibaba Health Information Technology Limited (ALI HEALTH, 00241.HK) disclosed that on 13 March 2026 it granted 3.88 million restricted share units (RSUs) to 20 employees under its 2024 Share Award Scheme.

• Grant details – Total RSUs: 3,881,600 units, each convertible into one ordinary share upon vesting. – Purchase price: Nil. – Closing price on grant date: HK$5.02 per share.

• Vesting schedule – RSUs vest in tranches over four years from the grant date. – Certain portions may vest within the first 12 months, in line with provisions allowing evenly distributed vesting periods of 12 months or more.

• Performance and clawback provisions – No performance targets are attached to the awards. – Unvested RSUs lapse automatically upon events such as termination for cause, ethical breaches, fraud, or conduct damaging to the group’s reputation.

• Remaining scheme capacity – 1.55 billion shares remain available for future grants under the overall mandate of the 2024 Share Award Scheme. – 160.92 million shares remain available under the scheme’s service-provider sub-limit.

The company stated that the awards aim to attract and retain talent, acknowledge employee contributions, and support future expansion goals. None of the grantees are directors, chief executives, substantial shareholders, related-entity participants, or service providers, and no financial assistance was provided for share purchases.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1125358983?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-13 20:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1125358983","market":"hk","top_or_hot":-1,"title":"ALI HEALTH (00241.HK) Grants 3.88 Million RSUs to 20 Employees; 1.55 Billion Shares Remain Available Under 2024 Scheme","media":"Bulletin Express","content":"<p>Alibaba Health Information Technology Limited (ALI HEALTH, 00241.HK) disclosed that on 13 March 2026 it granted 3.88 million restricted share units (RSUs) to 20 employees under its 2024 Share Award Scheme.</p>\n<p>• Grant details  \n  – Total RSUs: 3,881,600 units, each convertible into one ordinary share upon vesting.  \n  – Purchase price: Nil.  \n  – Closing price on grant date: HK$5.02 per share.</p>\n<p>• Vesting schedule  \n  – RSUs vest in tranches over four years from the grant date.  \n  – Certain portions may vest within the first 12 months, in line with provisions allowing evenly distributed vesting periods of 12 months or more.</p>\n<p>• Performance and clawback provisions  \n  – No performance targets are attached to the awards.  \n  – Unvested RSUs lapse automatically upon events such as termination for cause, ethical breaches, fraud, or conduct damaging to the group’s reputation.</p>\n<p>• Remaining scheme capacity  \n  – 1.55 billion shares remain available for future grants under the overall mandate of the 2024 Share Award Scheme.  \n  – 160.92 million shares remain available under the scheme’s service-provider sub-limit.</p>\n<p>The company stated that the awards aim to attract and retain talent, acknowledge employee contributions, and support future expansion goals. None of the grantees are directors, chief executives, substantial shareholders, related-entity participants, or service providers, and no financial assistance was provided for share purchases.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ALI HEALTH (00241.HK) Grants 3.88 Million RSUs to 20 Employees; 1.55 Billion Shares Remain Available Under 2024 Scheme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nALI HEALTH (00241.HK) Grants 3.88 Million RSUs to 20 Employees; 1.55 Billion Shares Remain Available Under 2024 Scheme\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-13 20:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alibaba Health Information Technology Limited (ALI HEALTH, 00241.HK) disclosed that on 13 March 2026 it granted 3.88 million restricted share units (RSUs) to 20 employees under its 2024 Share Award Scheme.</p>\n<p>• Grant details  \n  – Total RSUs: 3,881,600 units, each convertible into one ordinary share upon vesting.  \n  – Purchase price: Nil.  \n  – Closing price on grant date: HK$5.02 per share.</p>\n<p>• Vesting schedule  \n  – RSUs vest in tranches over four years from the grant date.  \n  – Certain portions may vest within the first 12 months, in line with provisions allowing evenly distributed vesting periods of 12 months or more.</p>\n<p>• Performance and clawback provisions  \n  – No performance targets are attached to the awards.  \n  – Unvested RSUs lapse automatically upon events such as termination for cause, ethical breaches, fraud, or conduct damaging to the group’s reputation.</p>\n<p>• Remaining scheme capacity  \n  – 1.55 billion shares remain available for future grants under the overall mandate of the 2024 Share Award Scheme.  \n  – 160.92 million shares remain available under the scheme’s service-provider sub-limit.</p>\n<p>The company stated that the awards aim to attract and retain talent, acknowledge employee contributions, and support future expansion goals. None of the grantees are directors, chief executives, substantial shareholders, related-entity participants, or service providers, and no financial assistance was provided for share purchases.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00241","symbol_name":"阿里健康","start_time":0,"source_url":"","article_id":"1125358983","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1125358983","pubTimestamp":1773405672,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Alibaba Health Information Technology Limited (ALI HEALTH, 00241.HK) disclosed that on 13 March 2026 it granted 3.88 million restricted share units (RSUs) to 20 employees under its 2024 Share Award...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00241":"阿里健康"},"translate_title":"阿里健康（00241.HK）向20名员工授出388万份受限制股份单位；根据2024年计划，仍有15.5亿股可供使用","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1},"content_text":"Alibaba Health Information Technology Limited (ALI HEALTH, 00241.HK) disclosed that on 13 March 2026 it granted 3.88 million restricted share units (RSUs) to 20 employees under its 2024 Share Award Scheme.\n• Grant details  \n  – Total RSUs: 3,881,600 units, each convertible into one ordinary share upon vesting.  \n  – Purchase price: Nil.  \n  – Closing price on grant date: HK$5.02 per share.\n• Vesting schedule  \n  – RSUs vest in tranches over four years from the grant date.  \n  – Certain portions may vest within the first 12 months, in line with provisions allowing evenly distributed vesting periods of 12 months or more.\n• Performance and clawback provisions  \n  – No performance targets are attached to the awards.  \n  – Unvested RSUs lapse automatically upon events such as termination for cause, ethical breaches, fraud, or conduct damaging to the group’s reputation.\n• Remaining scheme capacity  \n  – 1.55 billion shares remain available for future grants under the overall mandate of the 2024 Share Award Scheme.  \n  – 160.92 million shares remain available under the scheme’s service-provider sub-limit.\nThe company stated that the awards aim to attract and retain talent, acknowledge employee contributions, and support future expansion goals. None of the grantees are directors, chief executives, substantial shareholders, related-entity participants, or service providers, and no financial assistance was provided for share purchases.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1125358983","isCrawlerRequest":true}